PROTAGONIST THERAPEUTICS INC

Watch

Share

PTGX·74366E102·US·Common Stock·Healthcare - Biotechnology-13D/G

PTGX (PROTAGONIST THERAPEUTICS INC) is held by 171 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($1.3B), FARALLON CAPITAL MANAGEMENT, L.L.C. ($778.2M), RTW INVESTMENTS, LP ($620.4M). Net institutional sentiment: Mixed.

171

Holders

(13 Elite)

$8.2B

Total Value

62% (173)

Consensus

107 buying - 66 selling

13F: Jun 30, 2026Insider & Congress: Updated regularly

Smart Money Verdict

View all

Loading verdict

Institutional (13F)84

Insider (Form 4)77

Activist (13D/13G)85

Congressional (STOCK Act)68

Holder Quality

20

★★★★★

Elite

26

★★★★

Strong

28

★★★

Solid

66

★★

Below

27

★

Weak

Held by 171 funds

13 elite

Who's Trading

Source dates: Price Oct 16, 2026 · Insiders Oct 2, 2026 · Activists Aug 13, 2026 · Congress none

InsiderAAAli AsifExercise 5K shSep 30, 2026

InsiderAAAli AsifSell $1.8MSep 30, 2026

InsiderAAAli AsifSell $6.5MSep 30, 2026

Checking access…

View all insider tradesView all activist filings

Top Holders

Top Holders (171)History

AllNewIncreasedHeldDecreasedExitedFirst report

Checking access…

Fund	Action	Shares	Value	Weight	Est. P&L	Conviction
BlackRock, Inc.	Increased	10.3M(+5.4%)	$1.3B	0.0%	+154.30%	34
FARALLON CAPITAL MANAGEMENT, L.L.C.	Unchanged	6.3M	$778.2M	3.6%	+483.32%	0
RTW INVESTMENTS, LP	Increased	5.1M(+0.0%)	$620.4M	5.3%	+428.94%	61
VPVANGUARD PORTFOLIO MANAGEMENT LLC	Increased	3.6M(+4.3%)	$444.9M	0.0%	+21.35%	33
WELLINGTON MANAGEMENT GROUP LLP	Decreased	3.4M(-5.1%)	$418.8M	0.1%	+81.86%	0
UBS Group AG	Decreased	3.4M(-34.4%)	$416.7M	0.1%	+54.62%	0
STATE STREET CORP	Increased	3.3M(+6.6%)	$407.2M	0.0%	+226.52%	33
VAVANGUARD CAPITAL MANAGEMENT LLC	Increased	2.9M(+1.7%)	$349.8M	0.0%	+21.82%	32
Invesco Ltd.	Increased	2.3M(+8.1%)	$286.9M	0.0%	+63.96%	33
PRICE T ROWE ASSOCIATES INC /MD/	Increased	2.1M(+29.1%)	$263.5M	0.0%	+84.42%	39
JTJupiter Topco LLC	First report	2.1M	$261M	0.1%	+5.03%	0
GEODE CAPITAL MANAGEMENT, LLC	Increased	1.7M(+4.3%)	$213.5M	0.0%	+232.51%	32
Woodline Partners LP	Unchanged	1.4M	$173.3M	0.5%	+166.46%	0
BANK OF AMERICA CORP /DE/	Increased	1.3M(+2.2%)	$162.4M	0.0%	+86.55%	31
JENNISON ASSOCIATES LLC	Increased	1.2M(+7.4%)	$141.2M	0.1%	+26.98%	33
MORGAN STANLEY	Decreased	905,992(-11.0%)	$111.1M	0.0%	+119.26%	0
AIAlyeska Investment Group, L.P.	Increased	889,298(+49.9%)	$109M	0.3%	+20.25%	50
Hood River Capital Management LLC	Increased	882,738(+6.5%)	$108.2M	0.8%	+20.96%	45
GOLDMAN SACHS GROUP INC	Increased	812,852(+4.3%)	$99.6M	0.0%	+177.79%	31
DRIEHAUS CAPITAL MANAGEMENT LLC	Increased	731,053(+1.4%)	$89.6M	0.5%	+137.97%	43

Showing 1-20 of 183

Per page:

1 / 10

PTGXPROTAGONIST THERAPEUTICS INC

1M3M6M1Y3Y5Y

Continue exploring

Smart money flow

Track where institutional capital is flowing

Discover new institutional entries

Fresh positions initiated this quarter

Check sector trends

Capital flows across GICS sectors

Other Healthcare stocks held by institutions

UNHUNITEDHEALTH GROUP INC

417 holders · $300.5B

LLYELI LILLY & CO

416 holders · $881.6B

TMOTHERMO FISHER SCIENTIFIC INC

401 holders · $151.5B

JNJJOHNSON & JOHNSON

398 holders · $415.6B

DHRDANAHER CORP DEL

395 holders · $98.9B

ISRGINTUITIVE SURGICAL INC

394 holders · $111.8B

MRKMERCK & CO INC

391 holders · $230.3B

ABBVABBVIE INC

386 holders · $303.9B

BSXBOSTON SCIENTIFIC CORP

386 holders · $52.4B

ABTABBOTT LABORATORIES

383 holders · $114.2B

High Conviction Moves-Smart Money Convergence-Fund Consensus-Double-Down Detection

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer